KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $4,926,000 | -3.0% | 493,584 | +23.7% | 0.01% | 0.0% |
| Q1 2015 | $5,078,000 | +27.8% | 398,911 | +42.1% | 0.01% | +20.0% |
| Q4 2014 | $3,973,000 | +9.9% | 280,804 | +6.8% | 0.01% | +11.1% |
| Q3 2014 | $3,616,000 | -2.2% | 262,966 | +9.4% | 0.01% | 0.0% |
| Q2 2014 | $3,697,000 | -26.9% | 240,361 | -19.0% | 0.01% | -35.7% |
| Q1 2014 | $5,058,000 | +79.9% | 296,817 | +36.8% | 0.01% | +55.6% |
| Q4 2013 | $2,811,000 | -2.3% | 217,031 | -23.8% | 0.01% | -10.0% |
| Q3 2013 | $2,878,000 | +59.9% | 284,901 | +18.2% | 0.01% | +25.0% |
| Q2 2013 | $1,800,000 | – | 241,013 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,312,006 | $16,990,000 | 16.50% |
| VHCP Management, LLC | 1,000,273 | $12,954,000 | 6.97% |
| Cormorant Asset Management, LP | 1,700,000 | $22,015,000 | 6.39% |
| HARVEY CAPITAL MANAGEMENT INC | 890,500 | $11,531,000 | 4.76% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 859,672 | $11,133,000 | 2.50% |
| Rhenman & Partners Asset Management AB | 400,000 | $5,180,000 | 2.03% |
| SECTORAL ASSET MANAGEMENT INC | 2,758,950 | $35,728,000 | 1.54% |
| NORTHPOINTE CAPITAL LLC | 1,289,711 | $16,701,000 | 1.47% |
| Knoll Capital Management, LLC | 200,000 | $2,592,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,483,260 | $19,208,000 | 1.00% |